PETHEMA-BLIN-01/PET069014 (BLIN-01)

Clinical trial NCT03523429 · TERMINATED

Trial details

NCT number: NCT03523429
Sponsor: PETHEMA Foundation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL

Start date: 2018-06-30
Primary completion: 2019-12-24
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.